Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an α-ketothiazole arginine
摘要:
Using an alpha-ketothiazole arginine moiety as a key recognition element, a series of small peptidomimetic molecules was designed and synthesized, and their co-crystal structures with factor XIa were Studied in an effort to develop smaller, less peptidic inhibitors as antithrombotic agents. (c) 2006 Elsevier Ltd. All rights reserved.
Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an α-ketothiazole arginine
摘要:
Using an alpha-ketothiazole arginine moiety as a key recognition element, a series of small peptidomimetic molecules was designed and synthesized, and their co-crystal structures with factor XIa were Studied in an effort to develop smaller, less peptidic inhibitors as antithrombotic agents. (c) 2006 Elsevier Ltd. All rights reserved.
A new route of synthesis of the compound Aliskiren of formula (I), used in the treatment of hypertension, is described.
描述了一种用于治疗高血压的化合物阿利司钠(分子式为(I))的新合成途径。
PROCESS FOR PRODUCING ALISKIREN
申请人:Chemo Iberica, S.A.
公开号:EP2576500A2
公开(公告)日:2013-04-10
US9346745B2
申请人:——
公开号:US9346745B2
公开(公告)日:2016-05-24
[EN] PROCESS FOR PRODUCING ALISKIREN<br/>[FR] PROCÉDÉ DE PRODUCTION D'ALISKIREN
申请人:CHEMO IBERICA SA
公开号:WO2011151442A2
公开(公告)日:2011-12-08
A new route of synthesis of the compound Aliskiren of formula (I), used in the treatment of hypertension, is described.
Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an α-ketothiazole arginine
作者:Hongfeng Deng、Thomas D. Bannister、Lei Jin、Robert E. Babine、Jesse Quinn、Pamela Nagafuji、Cassandra A. Celatka、Jian Lin、Tsvetelina I. Lazarova、Michael J. Rynkiewicz、Frank Bibbins、Pramod Pandey、Joan Gorga、Harold V. Meyers、Sherin S. Abdel-Meguid、James E. Strickler
DOI:10.1016/j.bmcl.2006.02.052
日期:2006.6
Using an alpha-ketothiazole arginine moiety as a key recognition element, a series of small peptidomimetic molecules was designed and synthesized, and their co-crystal structures with factor XIa were Studied in an effort to develop smaller, less peptidic inhibitors as antithrombotic agents. (c) 2006 Elsevier Ltd. All rights reserved.